Syria Chemical Mission May Suffer Fallout From Ukraine Crisis

Global Security Newswire Staff
March 14, 2014, 8:40 a.m.

Wash­ing­ton’s top dip­lo­mat said it is un­clear how ten­sions over Ukraine could af­fect the re­mov­al of chem­ic­al arms from Syr­ia, Agence France-Presse re­ports.

Rus­sia played a cru­cial role in per­suad­ing Syr­i­an Pres­id­ent Bashar As­sad’s gov­ern­ment to cut 38 days from a re­vised timeline for re­lin­quish­ing its re­main­ing chem­ic­al-war­fare ma­ter­i­als, Sec­ret­ary of State John Kerry said on Thursday.

“We be­lieve that could now be re­duced by an­oth­er 20 to 25 days, and we’d like to see that done,” he told law­makers at a Sen­ate Ap­pro­pri­ations Com­mit­tee hear­ing.

However, “wheth­er or not we can suc­ceed in get­ting that done will de­pend to some de­gree on the out­come of events … with re­spect to Ukraine,” Kerry said. “My hope is … that events in Ukraine will not in­ter­fere.”

Ten­sions have soared between Mo­scow and West­ern cap­it­als fol­low­ing the Rus­si­an mil­it­ary oc­cu­pa­tion of Ukraine’s Crimean Pen­in­sula at the start of this month. The sides have ex­changed threats of polit­ic­al and eco­nom­ic re­pris­als as Crimean res­id­ents pre­pared for a Sunday vote on wheth­er to pull away from Ukraine’s new, pro-West­ern in­ter­im gov­ern­ment.

On Fri­day, though, a Rus­si­an For­eign Min­istry in­sider sug­ges­ted the Syr­i­an dis­arm­a­ment op­er­a­tion would move for­ward as planned, Re­u­ters re­por­ted.

“If there are no dif­fi­culties then in a month, on April 13, the re­mov­al will be prac­tic­ally fin­ished,” Mikhail Uly­an­ov, head of the se­cur­ity and dis­arm­a­ment de­part­ment, said in a re­port by the state-run RIA Nov­osti news agency.

Kerry sug­ges­ted that “Rus­sia main­tains a sig­ni­fic­ant in­terest in not hav­ing [Syr­ia’s] chem­ic­al weapons loose, not hav­ing them fall in­to the hands of ter­ror­ists.”

As­sad’s gov­ern­ment — a close part­ner of Mo­scow — agreed to give up the chem­ic­als after an Au­gust sar­in-gas at­tack on an op­pos­i­tion-held area promp­ted in­ter­na­tion­al mil­it­ary threats. Ob­serv­ers have ques­tioned the Syr­i­an re­gime’s abil­ity to fully pro­tect the ma­ter­i­als from seizure by oth­er groups fight­ing in Syr­ia’s civil war, which is now en­ter­ing its fourth year.

What We're Following See More »
SEVEN-POINT LEAD IN A FOUR-WAY
Quinnipiac Has Clinton Over 50%
29 minutes ago
THE LATEST

Hillary Clinton leads Donald Trump 51%-41% in a new Quinnipiac poll released today. Her lead shrinks to seven points when the third-party candidates are included. In that scenario, she leads 45%-38%, with Gary Johnson pulling 10% and Jill Stein at 4%.

Source:
PROCEDURES NOT FOLLOWED
Trump Not on Ballot in Minnesota
2 hours ago
THE LATEST
MIGHT STILL ACCEPT FOREIGN AND CORPORATE MONEY
Chelsea to Stay on Board of Clinton Foundation
2 hours ago
THE LATEST

Is the Clinton family backtracking on some of its promises to insulate the White House from the Clinton Foundation? Opposition researchers will certainly try to portray it that way. A foundation spokesman said yesterday that Chelsea Clinton will stay on its board, and that the "foundation’s largest project, the Clinton Health Access Initiative, might continue to accept foreign government and corporate funding."

Source:
INTERCEPT IN MIDDLE EAST
Navy Calls Iranian Ships’ Actions Dangerous, Unprofessional
3 hours ago
THE LATEST

"Four Iranian ships made reckless maneuvers close to a U.S. warship this week, the Pentagon said Thursday, in an incident that officials said could have led to dangerous escalation." The four Iranian vessels engaged in a "high-speed intercept" of a U.S. destroyer in the Strait of Hormuz. A Navy spokesman said the Iranina actions "created a dangerous, harassing situation that could have led to further escalation including additional defensive measures" by the destroyer.

Source:
$300 SAVINGS CARD
Under Pressure, EpiPen Maker Drops Prices
3 hours ago
THE LATEST

Amid public outcry and the threat of investigation by the Senate Judiciary Committee, Mylan has agreed to effectively drop the price of EpiPens. "The company, which did not lower the drug's list price, said it would reduce the patient cost of EpiPen through the use of a savings card, which will cover up to $300 of EpiPen 2-Pak."

Source:
×